Suppr超能文献

胸苷酸合成酶活性在肾细胞癌中的意义。

Significance of thymidylate synthase activity in renal cell carcinoma.

作者信息

Mizutani Yoichi, Wada Hiromi, Yoshida Osamu, Fukushima Masakazu, Nonomura Mitsuo, Nakao Masahiro, Miki Tsuneharu

机构信息

Department of Urology, Kyoto Prefectural University of Medicine, Kyoto 602-8566.

出版信息

Clin Cancer Res. 2003 Apr;9(4):1453-60.

Abstract

PURPOSE

5-Fluorouracil (5-FU) is an anticancer agent clinically used against various cancers including renal cell carcinoma (RCC). 5-FU inhibits thymidylate synthase (TS) and blocks DNA synthesis. TS is the key enzyme in the catalysis of the methylation from dUMP to dTMP in the DNA synthetic process. Little is known about the significance of TS in RCC. We investigated the activity of TS in 68 RCCs and the association with dihydropyrimidine dehydrogenase (DPD) activities, which is a principal enzyme in the degradation of 5-FU and pyrimidine nucleotides. The relationship between TS/DPD activities in primary cultured RCC cell lines and their sensitivity to 5-FU was also examined.

EXPERIMENTAL DESIGN

The levels of TS and DPD activities in nonfixed fresh-frozen RCC and normal kidney were determined biochemically by the 5-fluoro-2'-deoxyuridine 5'-monophosphate binding assay and the 5-FU degradation assay, respectively. The sensitivity of primary cultured RCC cells to 5-FU was assessed by the microculture tetrazolium dye assay.

RESULTS

The activity of TS was approximately 5-fold higher in RCC compared with normal kidney. TS activity in T(3/4) RCC was 2.5-fold higher than that in T(1/2) RCC. TS activity in M(1) RCC was 2.5-fold higher than that in M(0) RCC. In addition, TS activity in stage III/IV RCC was 3-fold higher than that in stage I/II RCC. The levels of TS activity in grade 3 RCC were 3-fold and 2-fold higher than that in grade 1 and grade 2 cancer, respectively. TS activity in clear cell RCC were 4-fold higher than that in papillary RCC. Patients with low TS activity had a longer disease-specific survival as compared with those with high activity in the 5-year follow-up. There was no relationship between TS and DPD activities. TS activity in primary cultured RCC cells was positively correlated with their sensitivity to 5-FU. Furthermore, RCC cells with both high TS activity and low DPD activity were more sensitive to 5-FU, compared with those with either low TS activity or high DPD activity.

CONCLUSIONS

The present study is the first study to demonstrate that the level of TS activity was correlated with both the progression of the stage and the increase of the grade of RCC, and that higher TS activity in primary cultured RCC predicted higher sensitivity to 5-FU. These results suggest that high TS activity may be associated with malignant potential of RCC, and that it may be possible to use 5-FU for RCC with high TS activity.

摘要

目的

5-氟尿嘧啶(5-FU)是一种临床上用于治疗包括肾细胞癌(RCC)在内的多种癌症的抗癌药物。5-FU抑制胸苷酸合成酶(TS)并阻断DNA合成。TS是DNA合成过程中催化dUMP甲基化生成dTMP的关键酶。关于TS在RCC中的意义知之甚少。我们研究了68例RCC中TS的活性及其与二氢嘧啶脱氢酶(DPD)活性的关系,DPD是5-FU和嘧啶核苷酸降解的主要酶。还检测了原发性培养的RCC细胞系中TS/DPD活性与其对5-FU敏感性之间的关系。

实验设计

分别通过5-氟-2'-脱氧尿苷5'-单磷酸结合试验和5-FU降解试验,生化测定非固定新鲜冷冻的RCC和正常肾脏中TS和DPD的活性水平。通过微量培养四氮唑染料试验评估原发性培养的RCC细胞对5-FU的敏感性。

结果

与正常肾脏相比,RCC中TS的活性约高5倍。T(3/4)期RCC中TS的活性比T(1/2)期RCC高2.5倍。M(1)期RCC中TS的活性比M(0)期RCC高2.5倍。此外,III/IV期RCC中TS的活性比I/II期RCC高3倍。3级RCC中TS活性水平分别比1级和2级癌症高3倍和2倍。透明细胞RCC中TS的活性比乳头状RCC高4倍。在5年随访中,TS活性低的患者比活性高的患者具有更长的疾病特异性生存期。TS和DPD活性之间没有关系。原发性培养的RCC细胞中TS的活性与其对5-FU的敏感性呈正相关。此外,与TS活性低或DPD活性高的细胞相比,TS活性高且DPD活性低的RCC细胞对5-FU更敏感。

结论

本研究首次表明TS活性水平与RCC的分期进展和分级增加均相关,并且原发性培养的RCC中较高的TS活性预示着对5-FU的更高敏感性。这些结果表明高TS活性可能与RCC的恶性潜能相关,并且对于TS活性高的RCC可能可以使用5-FU进行治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验